Hallo! Tracked shipping to Austria with Delivery Duty Paid for just €3.99  

Ship to
Austria
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Select your country

Americas

Europe

Rest of the world

portada Concomitant Tuberculosis Infection in HIV-positive Patients
Type
Physical Book
Publisher
Language
English
Pages
74
Format
Paperback
Dimensions
21x14.8x0.5 cm
Weight
0.11 kg.
ISBN13
9783346788863

Concomitant Tuberculosis Infection in HIV-positive Patients

Hirdesh Kumari Gupta (Author) · Abhishek Mehta (Author) · Grin Verlag · Paperback

Concomitant Tuberculosis Infection in HIV-positive Patients - Gupta, Hirdesh Kumari ; Mehta, Abhishek

New Book Imported to Austria
Delivery: 01 Oct - 05 Oct Shipping: 13 to 14 business days.
59,20 €
Import costs and 10% VAT included in the price ✅
59,20 €

Synopsis "Concomitant Tuberculosis Infection in HIV-positive Patients"

Document from the year 2015 in the subject Biology - Micro- and Molecular Biology, grade: A, course: Dept. of Microbiology, MLB Medical college, Jhansi, language: English, abstract: Mycobacterium tuberculosis (TB) and human immune deficiency virus (HIV) infections are two major public health problems in many parts of the world, particularly in many developing countries. TB is the most common opportunistic disease and cause of the death for those infected with HIV. Diagnosis of TB in HIV infected patients may be delayed because of atypical clinical presentation and involvement of inaccessible sites and low sputum smear positivity. Further, there has been an increase in rates of drug resistant tuberculosis, including multi-drug (MDR-TB) and extensively drug resistant TB (XDR-TB), which are difficult to treat and contribute to increased morbidity and mortality. TB is the most common serious opportunistic infection in HIV positive patients and is the manifestation of AIDS in more than 50% of cases in developing countries. TB shortens the survival of patients afflicted with HIV infection, may accelerate the progression of HIV, and is the cause of death in one third of people with AIDS worldwide. While HIV and TB can individually be the major causes for public health threats, the combination of the two has proven to have a far greater impact on the epidemiologic progression and consequently on the global health scene. Although the increased access to highly active antiretroviral therapy (HAART) has led to a reduction in HIV-associated opportunistic infections and hence mortality, but the concurrent management of HIV/TB co-infection remains a serious challenge to the health care delivery system. Discussion on the mechanisms produced by infectious cofactors with impact on disease pathology could shed light on how to design potential interventions that could decelerate disease progression. It is the need of the hour to design strategies against HIV-TB co-infection. Thi

Customers reviews

Frequently Asked Questions about the Book

All books in our catalog are Original.
The book is written in English.
The binding of this edition is Paperback.

Questions and Answers about the Book

Do you have a question about the book? Login to be able to add your own question.

Opinions about Bookdelivery

More customer reviews